Longterm Outcome of Children With Neonatal Intra-Ventricular or Intra-Cranial Hemorrhage

Overview

Intraventricular hemorrhage (IVH) is the most commonly recognized cerebral lesion on ultrasound in extremely preterm infants. Papile classification is commonly used to grade the severity of IVH. Grade III-IV IVH and other lesions noted on ultrasound including periventricular leukomalacia (pvl) porencephaly, and ventriculomegaly are well Documented to be associated with adverse neurodevelopmental outcomes. However, the true impact of lower-grade IVH on the neurodevelopment of these extreme preterm infants has not been well described. Also Neurodevelopmental outcome for neonatal non-traumatic Intra Cranial Hemorrhage (ICH) is not well established. The aim of this study is to look retrospectively at babies with neonatal IVH or ICH and follow their radiological, cognitive, motor and functional outcomes. The study will focus on postnatal files, and on images performed as part of the child's follow-up during hospitalization and after discharge.

Full Title of Study: “Longterm Outcome of Children With Neonatal Intra-Ventricular or Intra-Cranial Hemorrhage (IVH, ICH)”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: January 2027

Detailed Description

The study will be performed as a Retrospective chart review with key words : IVH, ICH of babies discharged from Laniado Hospital Neonatal care service or ICU, or being followed in the pediatric neurosurgical clinic and prematurity/neonatology clinic of the hospital. All charts of such children will be included, to review clinical, and radiological available data. Registration of Clinical, Radiological data as presented or submitted by the parents on Neurosurgical neonatology and Neurological Followups will be performed by PI or CI and coded in the data anonymously. Follow up will be performed as clinically indicated without addition of any specific studies due to the research. The endpoints of the study: primary endpoint: 1. How many children needed surgical intervention related to the hemorrhage (ICH, IVH) secondary endpoints: 2. Clinical and functional outcome of children – REGARDING normal schooling, need for assistance in ADL in difference from the parallel normal child. correlation between the type of hemorrhage, clinical data related to gestational age and weight at birth, and outcomes will be performed.

Arms, Groups and Cohorts

  • enrolled babies with neonatal intracranial bleed
    • all babies who suffered from intra cranial or intraventricular bleed during neonatal period

Clinical Trial Outcome Measures

Primary Measures

  • need for surgery related to neonatal hemorrhage
    • Time Frame: 3 years

Secondary Measures

  • normal schooling according to age
    • Time Frame: 6 years
  • need for ADL assistance beyond acceptable per age
    • Time Frame: 6 years

Participating in This Clinical Trial

Inclusion Criteria

newborns or premature babies who suffered intra-cranial or intra-ventricular hemorrhage children who are followed by PI in the neurosurgical clinic in Laniado hospital and suffered from ICH or IVH and were treated elsewhere after birth - Exclusion Criteria:

loss to followup within the first year after birth -

Gender Eligibility: All

Minimum Age: 1 Hour

Maximum Age: 3 Months

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Laniado Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Laniado Hospital, Liana.Adani – Laniado Hospital
  • Overall Contact(s)
    • LIANA ADANI BENI, MD, 97298609336, DRLIANA.PEDNS@GMAIL.COM

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.